New appointment at TranScrip Partners
This article was originally published in Scrip
TranScrip Partners (UK), a pharmaceutical development firm that provides advice and support to pharmaceutical and biotechnology companies, has appointed Gareth Walters partner. He has more than 20 years' experience in regulatory affairs, clinical research and product management, having most recently served as regional director of medicines development for Europe and the US at Choice Pharma. Mr Walters has also served as project leader of global regulatory affairs at Roche. After that, he joined the founding management team of Protigm, a drug development company and Roche subsidiary, which subsequently became Fulcrum Pharma.
You may also be interested in...
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.